A. Sabouraud

1.1k total citations
37 papers, 830 citations indexed

About

A. Sabouraud is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, A. Sabouraud has authored 37 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Nephrology. Recurrent topics in A. Sabouraud's work include Ion channel regulation and function (8 papers), Venomous Animal Envenomation and Studies (6 papers) and Gout, Hyperuricemia, Uric Acid (6 papers). A. Sabouraud is often cited by papers focused on Ion channel regulation and function (8 papers), Venomous Animal Envenomation and Studies (6 papers) and Gout, Hyperuricemia, Uric Acid (6 papers). A. Sabouraud collaborates with scholars based in France, Germany and United States. A. Sabouraud's co-authors include J.M. Scherrmann, J M Scherrmann, Myriam Rochdi, M. Urtizberea, Frédéric J. Baud, C Bismuth, Cassian Bon, F. Audebert, Jean‐Michel Scherrmann and C. Girre and has published in prestigious journals such as New England Journal of Medicine, Analytical Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A. Sabouraud

36 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Sabouraud France 15 348 213 213 143 134 37 830
Yuen Tan China 18 436 1.3× 44 0.2× 88 0.4× 46 0.3× 20 0.1× 41 1.4k
Alicja Wiercińska‐Drapało Poland 17 344 1.0× 26 0.1× 132 0.6× 26 0.2× 173 1.3× 119 1.3k
Lucinda Furci Italy 17 468 1.3× 46 0.2× 130 0.6× 22 0.2× 28 0.2× 28 1.5k
Leslie Obert United States 15 121 0.3× 53 0.2× 101 0.5× 84 0.6× 11 0.1× 29 770
M.A. Gougerot-Pocidalo France 14 164 0.5× 31 0.1× 44 0.2× 20 0.1× 55 0.4× 28 759
Patricia S. Latham United States 18 375 1.1× 35 0.2× 31 0.1× 39 0.3× 25 0.2× 58 1.1k
A. Abraham United States 16 250 0.7× 269 1.3× 49 0.2× 5 0.0× 109 0.8× 32 817
Brian K. Adler United States 13 383 1.1× 32 0.2× 47 0.2× 101 0.7× 17 0.1× 24 928
Henrike L. Schieferdecker Germany 18 165 0.5× 13 0.1× 65 0.3× 39 0.3× 29 0.2× 27 847
Lewis Glasser United States 15 153 0.4× 55 0.3× 64 0.3× 32 0.2× 104 0.8× 39 688

Countries citing papers authored by A. Sabouraud

Since Specialization
Citations

This map shows the geographic impact of A. Sabouraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sabouraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sabouraud more than expected).

Fields of papers citing papers by A. Sabouraud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sabouraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sabouraud. The network helps show where A. Sabouraud may publish in the future.

Co-authorship network of co-authors of A. Sabouraud

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sabouraud. A scholar is included among the top collaborators of A. Sabouraud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sabouraud. A. Sabouraud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mantel, Nathalie, et al.. (2018). Replacement of primary monkey kidney cells by L20B cell line in the test for effective inactivation of inactivated poliovirus vaccine. Journal of Virological Methods. 256. 77–84. 1 indexed citations
3.
Caulfield, Michael J., et al.. (2000). Immunogenicity of a hexavalent combination vaccine in rhesus monkeys. Vaccine. 19(7-8). 902–907. 6 indexed citations
4.
Sabouraud, A., et al.. (1999). Typing of rabies virus isolates by DNA enzyme immunoassay. Journal of Clinical Virology. 12(1). 9–19. 4 indexed citations
5.
Sabouraud, A., et al.. (1996). Dose-dependent reversal of digoxin-inhibited activity of an in vitro Na+K+ATPase model by digoxin-specific antibody. Toxicology Letters. 85(2). 107–111. 10 indexed citations
6.
Choumet, Valérie, F. Audebert, Gilles Rivière, et al.. (1996). New Approaches in Antivenom Therapy. Advances in experimental medicine and biology. 391. 515–520. 3 indexed citations
7.
Baud, Frédéric J., A. Sabouraud, Éric Vicaut, et al.. (1995). Treatment of Severe Colchicine Overdose with Colchicine-Specific Fab Fragments. New England Journal of Medicine. 332(10). 642–645. 153 indexed citations
8.
Sabouraud, A., et al.. (1995). Monoclonal Digoxin-Specific Antibodies Induce Dose-and Affinity-Dependent Plasma Digoxin Redistribution in Rats. Pharmaceutical Research. 12(5). 709–714. 13 indexed citations
9.
Audebert, F., M. Urtizberea, A. Sabouraud, J M Scherrmann, & Cassian Bon. (1994). Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1512–1517. 58 indexed citations
10.
Sabouraud, A., et al.. (1994). Radioimmunoassay of Colchicine with Antisera Exhibiting Variable Cross-Reactivity. Therapeutic Drug Monitoring. 16(2). 179–185. 16 indexed citations
11.
Audebert, F., et al.. (1993). Quantitation of Venom Antigens from European Vipers in Human Serum or Urine by ELISA. Journal of Analytical Toxicology. 17(4). 236–240. 26 indexed citations
12.
Sabouraud, A., et al.. (1993). Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.. Drug Metabolism and Disposition. 21(6). 997–1002. 6 indexed citations
13.
Sabouraud, A., et al.. (1993). Development of a Sensitive Radioimmunoassay for Fab Fragments: Application to Fab Pharmacokinetics in Humans. Pharmaceutical Research. 10(5). 692–696. 9 indexed citations
14.
Urtizberea, M., A. Sabouraud, Frédéric J. Baud, et al.. (1992). Concepts for Toxicokinetic-Toxicodynamic Modelling in Clinical Toxicology: Application to Acute Cardiac Glycoside Intoxications. Archives of toxicology. Supplement. 15. 253–256. 3 indexed citations
15.
Sabouraud, A., et al.. (1992). Analytical Control Procedures of Immunoreactivity for IgG and Fab Fragments Specific to Haptens. Pharmaceutical Research. 9(5). 643–647. 5 indexed citations
16.
Sabouraud, A., et al.. (1992). Colchicine-specific Fab fragments alter colchicine disposition in rabbits.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1214–1219. 36 indexed citations
17.
Urtizberea, M., et al.. (1991). Reversal of murine colchicine toxicity by colchicine-specific Fab fragments. Toxicology Letters. 58(2). 193–198. 15 indexed citations
18.
Urtizberea, M., A. Sabouraud, Olivier Chappey, et al.. (1991). Pharmacokinetics of Total and Free Digoxin and Fab Fragments in 5 Intoxicated Patients after Administration of Specific Anti-Digoxin Fab Fragments. Archives of toxicology. Supplement. 14. 132–135. 5 indexed citations
19.
Sabouraud, A., Hélène Denis, M. Urtizberea, Olivier Chappey, & J M Scherrmann. (1990). The effect of nortriptyline-specific active immunization on amitriptyline toxicity and disposition in the rabbit. Toxicology. 62(3). 349–360. 2 indexed citations
20.
Sabouraud, A., et al.. (1990). Specific Anti-digoxin Fab Fragments: an Available Antidote for Proscillaridin and Scilliroside Poisoning?. Human & Experimental Toxicology. 9(3). 191–193. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026